《Investigation into the influence of an acrylic acid acceptor in organic D-π-A sensitizers against phototoxicity》 was published in Bioorganic & Medicinal Chemistry in 2020. These research results belong to Fuse, Shinichiro; Moriya, Wataru; Sato, Shinichi; Nakamura, Hiroyuki. Safety of 2,5-Dibromothiophene The article mentions the following:
Photodynamic therapy (PDT) is a non-invasive, selective, and cost-effective cancer therapy. We previously reported that thiophene-based organic D-π-A sensitizers consist of an electron-donating (D) moiety, a π-conjugated bridge (π) moiety, and an electron-accepting (A) moiety, and are readily accessible and stable templates for photosensitizers that could be used in PDT. In addition, acrylic acid acceptor-containing photosensitizers exert a high level of phototoxicity. This study was an investigation into 1) the possibility of increasing phototoxicity by introducing another carboxyl group or by replacing a carboxyl group with a pyridinium group, and 2) the importance of an alkene in the acrylic acid acceptor for phototoxicity. A review of the design, synthesis, and evaluation of sensitizers revealed that neither dicarboxylic acid nor pyridinium photosensitizers enhance phototoxicity. An evaluation of a photosensitizer without an alkene in the acrylic acid moiety revealed that the alkene was not indispensable in the pursuit of phototoxicity. The obtained results provided new insight into the design of ideal D-π-A photosensitizers for PDT. After reading the article, we found that the author used 2,5-Dibromothiophene(cas: 3141-27-3Safety of 2,5-Dibromothiophene)
2,5-Dibromothiophene(cas: 3141-27-3) , is mainly used as pharmaceutical intermediate and synthesis intermediate. 2,5-Dibromothiophene may be used in the preparation of soluble α,ω-diformyl-a-oligothiophenes.Safety of 2,5-Dibromothiophene
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary